Cliniques Universitaires Saint-Luc UCL

Brussels 1200

2 studies enrolling now · 8 studies all time

What they study most

Acute Kidney Injury, Breast Cancer, Chronic Hepatitis B, Focal Epilepsy, Focal Onset Seizures, HIV-1 Infection, Hepatitis C Virus Infection, Metastatic Breast Cancer, Tonic-Clonic Seizures

Studies at this site

• A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3) — Recruiting now
• An Open-label Study of XEN1101 in Epilepsy — Enrolling by invitation
• Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus Infection — Running, not enrolling
• Safety of Pregnancy in BRCA Mutated Breast Cancer Patients — Completed
• A Registry for Adolescent and Pediatric Participants Who Received a Gilead Hepatitis C Virus Direct Acting Antiviral (DAA) in Gilead-Sponsored Chronic Hepatitis C Infection Trials — Stopped early
• A Double-blind Study of Paclitaxel in Combination With Reparixin or Placebo for Metastatic Triple-Negative Breast Cancer — Completed
• A Safety, Tolerability, Efficacy and QoL Study of Human recAP in the Treatment of Patients With SA-AKI — Completed
• Study to Evaluate the Safety and Efficacy of a Single Tablet Regimen of Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Compared With a Single Tablet Regimen of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults — Completed